Colorectal Cancer Therapy Using a Pediococcus pentosaceus SL4 Drug Delivery System Secreting Lactic Acid Bacteria-Derived Protein p8 |
An, Byung Chull
(R&D Center, Cell Biotech, Co., Ltd.)
Ryu, Yongku (R&D Center, Cell Biotech, Co., Ltd.) Yoon, Yeo-Sang (R&D Center, Cell Biotech, Co., Ltd.) Choi, Oksik (R&D Center, Cell Biotech, Co., Ltd.) Park, Ho Jin (R&D Center, Cell Biotech, Co., Ltd.) Kim, Tai Yeub (R&D Center, Cell Biotech, Co., Ltd.) Kim, Song-In (R&D Center, Cell Biotech, Co., Ltd.) Kim, Bong-Kyu (R&D Center, Cell Biotech, Co., Ltd.) Chung, Myung Jun (R&D Center, Cell Biotech, Co., Ltd.) |
1 | Adriana, N., Anna, P., and Janusz, B. (2018). Anti-proliferative, proapoptotic and anti-oxidative activity of Lactobacillus and Bifidobacterium strains: A review of mechanisms and therapeutic perspectives. Crit. Rev. Food Sci. Nutr. 16, 1-12. |
2 | Cousin, F.J., Jouan-Lanhouet, S., Theret, N., Brenner, C., Jouan, E., MOigne-Muller, G.L., Dimanche-Boitrel, M.T., and Jan, G. (2016). The probiotic Propionibacterium freudenreichii as a new adjuvant for TRAIL-base therapy in colorectalcancer. Oncotarget 7, 7161-7178. DOI |
3 | Dantoft, S.H., Bielak, E.M., Seo, J.G., Chung, M.J., and Jensen, P.R. (2013). Complete genome sequence of Pediococcus pentosaceus strain SL4. Genome Announc. 1, e01106-e01113. |
4 | Drouault, S., Corthier, G., Ehrlich, S.D., and Renault, P. (1999). Survival, physiology, and lysis of Lactococcus lactis in the digestive tract. Appl. Environ. Microbiol. 65, 4881-4886. DOI |
5 | Flambard, B. and Juillard, V. (2000). The autoproteolysis of Lactococcus lactis lactocepin III affects its specificity towards beta-casein. Appl. Environ. Microbiol. 66, 5134-5140. DOI |
6 | Hendler, R. and Zhang, Y. (2018). Probiotics in the treatment of colorectal cancer. Medicines (Basel) 5, 1-14. DOI |
7 | Hormannsperger, G., von Schillde, M.A., and Haller, D. (2013). Lactocepin as a protective microbial structure in the context of IBD. Gut Microbes 4, 152-157. DOI |
8 | Makarova, K., Slesarev, A., Wolf, Y., Sorokin, A., Mirkin, B., Koonin, E., Pavlov, A., Pavlova, N., Karamychev, V., Polouchine, N., et al. (2006). Comparative genomics of the lactic acid bacteria. Proc. Natl. Acad. Sci. U. S. A. 103, 15611-15616. DOI |
9 | Kim, M.S., Kim, J.E., Yoon, Y.S., Kim, T.H., Seo, J.G., Chung, M.J., and Yum, D.Y. (2015). Improvement of atopic dermatitis-like skin lesions by IL-4 inhibition of P14 protein isolated from Lactobacillus casei in NC/Nga mice. Appl. Microbiol. Biotechnol. 99, 7089-7099. DOI |
10 | Ley, R.E., Hamady, M., Lozupone, C., Turnbaugh, P.J., Ramey, R.R., Bircher, J.S., Schlegel, M.L., Tucker, T.A., Schrenzel, M.D., Knight, R., et al. (2008). Evolution of mammals and their gut microbes. Science 320, 1647-1651. DOI |
11 | McWilliams, R.R. and Erlichman, C. (2005). Novel therapeutics in colorectal cancer. Dis. Colon Rectum 48, 1632-1650. DOI |
12 | Orlando, A., Refolo, M.G., Messa, C., Amati, L., Lavermicocca, P., Guerra, V., and Russo, F. (2012). Antiproliferative and proapoptotic effects of viable or heat-killed Lactobacillus paracasei IMPC2.1 and Lactobacillus rhamnosus GG in HGC-27 gastric and DLD-1 colon cell lines. Nutr. Cancer 64, 1103-1111. DOI |
13 | Papagianni, M. and Anastasiadou, S. (2009). Pediocins: the bacteriocins of pediococci. Sources, production, properties and applications. Microb. Cell Fact. 8, 3. DOI |
14 | Uccello, M., Malaguarnera, G., Basile, F., D'agata, V., Malaguarnera, M., Bertino, G., Vacante, M., Drago, F., and Biondi, A. (2012). Potential role of probiotics on colorectal cancer prevention. BMC Surg. 12 Suppl 1, S35. DOI |
15 | Quercia, S., Candela, M., Giuliani, C., Turroni, S., Luiselli, D., Rampelli, S., Brigidi, P., Franceschi, C., Bacalini, M.G., Garagnani, P., et al. (2014). From lifetime to evolution: timescales of human gut microbiota adaptation. Front. Microbiol. 5, 587. |
16 | Quigley, E.M. (2011). Gut microbiota and the role of probiotics in therapy. Curr. Opin. Pharmacol. 11, 593-603. DOI |
17 | Sadeghi-Aliabadi, H., Mohammadi, F., Fazeli, H., and Mirlohi, M. (2014). Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran. J. Basic Med. Sci. 17, 815-819. |
18 | Shin, M.S., Han, S.K., Ryu, J.S., Kim, K.S., and Lee, W.K. (2008). Isolation and partial characterization of a bacteriocin produced by P. pentosaceus K23-2 isolated from Kimchi. J. Appl. Microbiol. 105, 331-339. DOI |
19 | Steidler, L. and Vandenbroucke, K. (2006). Genetically modified Lactococcus lactis: novel tools for drug delivery. Int. J. Dairy Technol. 59, 140-146. DOI |
20 | von Schillde, M.A., Hormannsperger, G., Weiher, M., Alpert, C.A., Hahne, H., Bauerl, C., van Huynegem, K., Steidler, L., Hrncir, T., Perez-Martinez, G., et al. (2012). Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11, 387-396. DOI |
21 | Weitz, J., Koch, M., Debus, J., Hohler, T., Galle, P.R., and Büchler, M.W. (2005). Colorectal cancer. Lancet 365, 153-165. DOI |
22 | Widakowich, C., de Castro, G. Jr., de Azambuja, E., Dinh, P., and Awada, A. (2007). Review: side effects of approved molecular targeted therapies in solid cancers. Oncologist 12, 1443-1455. DOI |
23 | Yan, F., Cao, H., Cover, T.L., Whitehead, R., Washington, M.K., and Polk, D.B. (2007). Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology 132, 562-575. DOI |
24 | Zhong, L., Zhang, X., and Covasa, M. (2014). Emerging roles of lactic acid bacteria in protection against colorectal cancer. World J. Gastroenterol. 20, 7878-7886. DOI |
25 | Zakostelska, Z., Kverka, M., Klimesova, K., Rossmann, P., Mrazek, J., Kopecny, J., Hornova, M., Srutkova, D., Hudcovic, T., Ridl, J., et al. (2011). Lysate of probiotic Lactobacillus casei DN-114 001 ameliorates colitis by strengthening the gut barrier function and changing the gut microenvironment. PLoS One 6, e27961. DOI |
26 | Zhang, L., Ren, X., Alt, E., Bai, X., Huang, S., Xu, Z., Lynch, P.M., Moyer, M.P., Wen, X.F., and Wu, X. (2010). Chemoprevention of colorectal cancer by targeting APC-deficient cells for apoptosis. Nature 464, 1058-1061. DOI |
![]() |